| Vodobatinib |
K0706 |
1388803-90-4 |
| EGFR-IN-7 (compound 34) |
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 |
2267329-76-8 |
| NS 3623 |
NS 3623 |
343630-41-1 |
| 4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide |
4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺 |
312756-74-4 |
| AZ304 |
AZ304 |
942507-42-8 |
| AZD-2858 |
AZD2858 |
486424-20-8 |
| AST 487 |
AST 487 |
630124-46-8 |
| 4-((5'-chloro-2'-((1R,4r)-4-((R)-1-methoxypropan-2-ylamino)cyclohexylamino)-2,4'-bipyridin-6-ylamino)methyl)tetrahydro-2H-pyran-4-carbonitrile |
化合物NVP-2 |
1263373-43-8 |
| KEA1-97 |
KEA1-97 |
2138882-71-8 |
| GSK621 |
6-氯-5-(2'-羟基-3'-甲氧基-[1,1'-联苯]-4-基)-3-(3-甲氧基苯基)-1H-吡咯并[3,2-D]嘧啶-2,4(3H,5H)-二酮 |
1346607-05-3 |
| MPI-0479605 |
N6-环己基-N2-(2-甲基-4-吗啉苯基)-9H-嘌呤-2,6-二胺 |
1246529-32-7 |
| VU 0364770 |
VU 0364770 |
61350-00-3 |
| Panobinostat |
帕比司他 |
404950-80-7 |
| bis-2-(5-PhenylacetMido-1,2,4-Thiadiazol-2-yl)Ethyl Sulfide |
BPTES |
314045-39-1 |
| 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol |
4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-丁炔-2-醇 |
937174-76-0 |
| Ponatinib |
帕纳替尼 |
943319-70-8 |
| ABT 263 |
ABT 263 |
923564-51-6 |
| SC 144 |
吡嗪羧酸 2-(7-氟吡咯并[1,2-A]喹喔啉-4-基)酰肼 |
895158-95-9 |
| 2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl-benzoicacid |
2-环戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸 |
890842-28-1 |
| Bafetinib |
巴非替尼 |
887650-05-7 |
QQ
微信
